Statement on results of the HERS II trial on hormone replacement therapy.
D000367:Age Factors; D000368:Aged; D001943:Breast Neoplasms / Q000453:epidemiology; D015179:Colorectal Neoplasms / Q000517:prevention & control; D003327:Coronary Disease / Q000150:complications / Q000517:prevention & control; D015914:Estrogen Replacement Therapy; D005260:Female; D005500:Follow-Up Studies; D005705:Gallbladder Diseases / Q000453:epidemiology / Q000601:surgery; D006620:Hip Fractures / Q000517:prevention & control; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D017698:Postmenopause; D011655:Pulmonary Embolism / Q000453:epidemiology; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D012307:Risk Factors; D020521:Stroke / Q000209:etiology; D013997:Time Factors